{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T21:11:24Z","timestamp":1768684284953,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"51","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica (ANPCYT-Argentina)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.vaccine.2013.07.041","type":"journal-article","created":{"date-parts":[[2013,7,30]],"date-time":"2013-07-30T05:15:53Z","timestamp":1375161353000},"page":"6129-6135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["The vaccine candidate BLSOmp31 protects mice against Brucella canis infection"],"prefix":"10.1016","volume":"31","author":[{"given":"Maria","family":"Clausse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra G.","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giselle","family":"Ghersi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanesa","family":"Zylberman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"Cassataro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo H.","family":"Giambartolomei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando A.","family":"Goldbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia M.","family":"Estein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.07.041_bib0005","first-page":"2","article-title":"Canine brucellosis","volume":"8","author":"Wanke","year":"2004","journal-title":"Animal Reproduction Science"},{"key":"10.1016\/j.vaccine.2013.07.041_bib0010","series-title":"Canine Brucellosis Brucella canis. Contagious Abortion, Undulant Fever","year":"2007"},{"key":"10.1016\/j.vaccine.2013.07.041_bib0015","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1096-2867(96)80028-4","article-title":"Canine brucellosis: a diagnostician's dilemma","volume":"11","author":"Carmichael","year":"1996","journal-title":"Seminars in Veterinary Medicine and Surgery (Small Animals)"},{"key":"10.1016\/j.vaccine.2013.07.041_bib0020","series-title":"Recent Advances in Canine Infectious Diseases, 23 November 1999","article-title":"Canine brucellosis caused by Brucella canis","author":"Shin","year":"1999"},{"key":"10.1016\/j.vaccine.2013.07.041_bib0025","series-title":"Brucella Molecular and Cellular Biology","article-title":"Development of new brucella vaccines by molecular methods","author":"Hoover","year":"2004"},{"key":"10.1016\/j.vaccine.2013.07.041_bib0030","first-page":"371","article-title":"Problems in the serodiagnosis of canine brucellosis: dog responses to cell wall and internal antigens of Brucella canis","volume":"56","author":"Carmichael","year":"1984","journal-title":"Developments in Biological Standardization"},{"key":"10.1016\/j.vaccine.2013.07.041_bib0035","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3201\/eid1001.020622","article-title":"Infection with M- strain of Brucella canis","volume":"10","author":"Wallach","year":"2004","journal-title":"Emerging Infectious Diseases"},{"issue":"1","key":"10.1016\/j.vaccine.2013.07.041_bib0040","first-page":"61","article-title":"Vaccine antigens","volume":"1","author":"Strugnell","year":"2011","journal-title":"Understanding Modern Vaccines: Perspectives in Vaccinology"},{"key":"10.1016\/j.vaccine.2013.07.041_bib0045","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1286-4579(02)00075-8","article-title":"The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB\/c mice","volume":"5","author":"Estein","year":"2003","journal-title":"Microbes and Infection"},{"key":"10.1016\/j.vaccine.2013.07.041_bib0050","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.vetmic.2004.05.004","article-title":"Immunogenicity of recombinant Omp31 from Brucella melitensis in rams and serum bactericidal activity against B. ovis","volume":"102","author":"Estein","year":"2004","journal-title":"Veterinary Microbiology"},{"key":"10.1016\/j.vaccine.2013.07.041_bib0055","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1128\/IAI.73.10.6537-6546.2005","article-title":"A DNA vaccine coding for the Brucella Outer Membrane Protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response","volume":"73","author":"Cassataro","year":"2005","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.vaccine.2013.07.041_bib0060","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1128\/CVI.00472-06","article-title":"Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting","volume":"14","author":"Cassataro","year":"2007","journal-title":"Clinical and Vaccine Immunology"},{"key":"10.1016\/j.vaccine.2013.07.041_bib0065","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.1128\/IAI.71.10.5750-5755.2003","article-title":"Brucella Lumazine synthase elicits a mixed Th1\u2013Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used","volume":"71","author":"Velikovsky","year":"2003","journal-title":"Infection and Immunity"},{"issue":"5","key":"10.1016\/j.vaccine.2013.07.041_bib0070","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1128\/IAI.70.5.2507-2511.2002","article-title":"A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB\/c mice","volume":"70","author":"Velikovsky","year":"2002","journal-title":"Infection and Immunity"},{"issue":"9","key":"10.1016\/j.vaccine.2013.07.041_bib0075","doi-asserted-by":"crossref","first-page":"8093","DOI":"10.1074\/jbc.M312035200","article-title":"High order quaternary arrangement confers increased structural stability to Brucella spp. lumazine synthase","volume":"279","author":"Zylberman","year":"2004","journal-title":"The Journal of Biological Chemistry"},{"issue":"5","key":"10.1016\/j.vaccine.2013.07.041_bib0080","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.micinf.2005.12.006","article-title":"Brucella spp. lumazine synthase: a novel adjuvant and antigen delivery system to effectively induce oral immunity","volume":"8","author":"Rosas","year":"2006","journal-title":"Microbes and Infection"},{"key":"10.1016\/j.vaccine.2013.07.041_bib0085","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1016\/j.vaccine.2007.03.028","article-title":"A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against Brucella ovis than Rev. 1 vaccination","volume":"25","author":"Cassataro","year":"2007","journal-title":"Vaccine"},{"issue":"48","key":"10.1016\/j.vaccine.2013.07.041_bib0090","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1016\/j.vaccine.2009.08.097","article-title":"The polymeric antigen BLSOmp31 confers protection against Brucella ovis infection in rams","volume":"27","author":"Estein","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.07.041_bib0095","doi-asserted-by":"crossref","first-page":"5958","DOI":"10.1016\/j.vaccine.2007.05.049","article-title":"A DNA vaccine coding for the chimera BLSOmp31 induced a better degree of protection against Brucella ovis and a similar degree of protection against B. melitensis than Rev. 1 vaccination","volume":"25","author":"Cassataro","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.07.041_bib0100","series-title":"Inmunolog\u00eda e Inmunoqu\u00edmica Fundamentos","year":"1996"},{"issue":"2","key":"10.1016\/j.vaccine.2013.07.041_bib0105","first-page":"53","article-title":"Evaluation of a mouse infection model to evaluate homologue and heterologue vaccines against Brucella canis in mouse model","volume":"13","author":"Clausse","year":"2011","journal-title":"InVet"},{"key":"10.1016\/j.vaccine.2013.07.041_bib0110","first-page":"3","article-title":"A rapid slide agglutination test for the serodiagnosis of Brucella canis infection that employs a variant (M-) organism as antigen","volume":"77","author":"Carmichael","year":"1987","journal-title":"Cornell Veterinary"},{"issue":"4","key":"10.1016\/j.vaccine.2013.07.041_bib0115","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0092-1157(76)80019-4","article-title":"Transformation normalizing the distribution of the number of Brucella organisms in the spleen of rats vaccinated intraperitoneally","volume":"4","author":"Bosseray","year":"1976","journal-title":"Journal of Biological Standardization"},{"key":"10.1016\/j.vaccine.2013.07.041_bib0120","series-title":"Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, Bovine Brucellosis","author":"OIE","year":"2009"},{"key":"10.1016\/j.vaccine.2013.07.041_bib0125","series-title":"Canine Brucellosis Caused by Brucella canis","author":"Carmichael","year":"1999"},{"key":"10.1016\/j.vaccine.2013.07.041_bib0130","series-title":"Estudio de vacunas subcelulares contra la brucelosis","author":"Estein","year":"2006"},{"issue":"154","key":"10.1016\/j.vaccine.2013.07.041_bib0135","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.vetimm.2013.04.003","article-title":"Immune response and serum bactericidal activity against Brucella ovis elicited using a short immunization schedule with the polymeric antigen BLSOmp31 in rams","volume":"15","author":"D\u00edaz","year":"2013","journal-title":"Veterinary Immunology and Immunopathology"},{"key":"10.1016\/j.vaccine.2013.07.041_bib0140","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1099\/jmm.0.45927-0","article-title":"Diagnosis of human brucellosis caused by Brucella canis","volume":"54","author":"Lucero","year":"2005","journal-title":"Journal of Medical Microbiology"},{"issue":"1.","key":"10.1016\/j.vaccine.2013.07.041_bib0145","article-title":"Vaccine adjuvants","volume":"1","author":"Gar\u00e7on","year":"2011","journal-title":"Understanding Modern Vaccines: Perspectives in Vaccinology"},{"key":"10.1016\/j.vaccine.2013.07.041_bib0150","series-title":"The European Agency for the Evaluation of Medicinal Products","article-title":"Note for guidance on the use of adjuvanted veterinary vaccines","author":"CVMP\/IWP\/043\/97-FINAL","year":"1998"},{"issue":"3","key":"10.1016\/j.vaccine.2013.07.041_bib0155","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1128\/CMR.00005-07","article-title":"Current status of veterinary vaccines","volume":"20","author":"Meeusen","year":"2007","journal-title":"Clinical Microbiology Reviews"},{"key":"10.1016\/j.vaccine.2013.07.041_bib0160","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0264-410X(96)00183-1","article-title":"Adjuvants: a classification and review of their mode of action","volume":"15","author":"Cox","year":"1997","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2013.07.041_bib0165","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0167-5699(93)90046-N","article-title":"Adjuvants: current status, clinical perspectives and future prospects","volume":"14","author":"Audibert","year":"1993","journal-title":"Immunology Today"},{"key":"10.1016\/j.vaccine.2013.07.041_bib0170","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1099\/00222615-43-5-344","article-title":"Outer membrane protein and rough lipopolysaccharide specific monoclonal antibodies protect mice against Brucella ovis","volume":"43","author":"Bowden","year":"1995","journal-title":"Journal of Medical Microbiology"},{"key":"10.1016\/j.vaccine.2013.07.041_bib0175","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1128\/IAI.62.2.632-638.1994","article-title":"Protective immunity to Brucella ovis in BALB\/c mice following recovery from primary infection or immunization with subcellular vaccines","volume":"62","author":"Jim\u00e9nez De Bagu\u00e9s","year":"1994","journal-title":"Infection and Immunity"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13009845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13009845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T02:03:16Z","timestamp":1596247396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13009845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":35,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0264410X13009845"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.07.041","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The vaccine candidate BLSOmp31 protects mice against Brucella canis infection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.07.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}